Keratoacanthomas and skin neoplasms associated with suramin therapy.
Kobayashi
K
K
Pezen
D S
DS
Vogelzang
N J
NJ
Medenica
M
M
Janisch
L
L
Ratain
M
M
Vokes
E E
EE
Soltani
K
K
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D007636:Keratoacanthoma / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000139:chemically induced*; D013498:Suramin / Q000009:adverse effects*
D000970:Antineoplastic Agents; D013498:Suramin